Post by Boehringer Ingelheim

#NEWS: Hard-to-treat cancers demand new thinking and the right partners. That’s why we’re collaborating with Combotope Therapeutics ApS to explore novel tumor-selective antibody approaches. Together, we aim to advance next-generation cancer therapies to open new possibilities in oncology. Learn more: https://lnkd.in/e8ht-eCV #PrecisionOncology #CancerResearch #Partnership